Stanford Medicine researchers have developed an intranasal liposomal vaccine that protected mice against SARS-CoV-2, Staphylococcus aureus, other coronaviruses, and even common allergens, using a ...

Stanford Medicine researchers and collaborators have produced an intranasal liposomal vaccine that protected mice against multiple respiratory viruses, bacteria, and even allergens in a single ...

Approximately 40% of the European population is allergic to pollen, and their symptoms cause the estimated loss of 100 million school and work days every year. Traditional treatment is ...

A single antibody nasal spray could one day transform allergy relief, as scientists demonstrate powerful protection against pollen-induced sneezing and wheezing in mice. Study: Intranasal monoclonal ...